Analyst firms · H.C. Wainwright · AVDL
H.C. Wainwright AVDL price target and rating history
Avadel Pharmaceuticals plc (AVDL) · Health Care
H.C. Wainwright rates Avadel Pharmaceuticals plc (AVDL) Neutral with a $20 price target, as of its latest action on Oct 23, 2025. It has published 3 rating actions on AVDL since March 2024, including 0 upgrades and 1 downgrade.
- Current rating
- Neutral
- Price target
- $20
- Median target, all firms
- Too few
- Actions on AVDL
- 3
H.C. Wainwright price target on AVDL
Every H.C. Wainwright rating on AVDL
- Oct 23, 2025
- Jul 18, 2025
- Mar 5, 2024
Questions about H.C. Wainwright and AVDL
- What is H.C. Wainwright's price target for AVDL?
- H.C. Wainwright's latest stated price target for Avadel Pharmaceuticals plc (AVDL) is $20, from its action on Oct 23, 2025.
- What is H.C. Wainwright's rating on AVDL?
- H.C. Wainwright rates AVDL Neutral, a neutral rating, as of Oct 23, 2025.
- When did H.C. Wainwright last change its view on AVDL?
- On Oct 23, 2025, H.C. Wainwright downgrades to Neutral from Buy, price target $20.
More AVDL rating histories
All H.C. Wainwright ratingsAVDL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.